Number of the records: 1  

Structural characterization of P1 '-diversified urea-based inhibitors of glutamate carboxypeptidase II

  1. 1.
    0433586 - BTÚ 2015 RIV GB eng J - Journal Article
    Pavlíček, Jiří - Ptáček, Jakub - Černý, Jiří - Byun, Y. - Škultétyová, Ĺubica - Pomper, M.G. - Lubkowski, J. - Bařinka, Cyril
    Structural characterization of P1 '-diversified urea-based inhibitors of glutamate carboxypeptidase II.
    Bioorganic and Medicinal Chemistry Letters. Roč. 24, č. 10 (2014), s. 2340-2345. ISSN 0960-894X. E-ISSN 1464-3405
    R&D Projects: GA MŠMT(CZ) ED1.1.00/02.0109
    Grant - others:EMBO(DE) 1978
    Institutional support: RVO:86652036
    Keywords : GCPII * Prostate-specific membrane antigen * PSMA
    Subject RIV: FR - Pharmacology ; Medidal Chemistry
    Impact factor: 2.420, year: 2014

    Urea-based inhibitors of human glutamate carboxypeptidase II (GCPII) have advanced into clinical trials for imaging metastatic prostate cancer. In parallel efforts, agents with increased lipophilicity have been designed and evaluated for targeting GCPII residing within the neuraxis. Here we report the structural and computational characterization of six complexes between GCPII and P1 '-diversified urea-based inhibitors that have the C-terminal glutamate replaced by more hydrophobic moieties. The X-ray structures are complemented by quantum mechanics calculations that provide a quantitative insight into the GCPII/inhibitor interactions. These data can be used for the rational design of novel glutamate-free GCPII inhibitors with tailored physicochemical properties. (C) 2014 Elsevier Ltd. All rights reserved.
    Permanent Link: http://hdl.handle.net/11104/0238115

     
    FileDownloadSizeCommentaryVersionAccess
    Pavlicek_BioorgMedChemLett_24_2340_14.pdf61.3 MBPublisher’s postprintrequire
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.